Cite
MLA Citation
Minas P. Economides et al.. “Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm.” Expert review of clinical pharmacology, vol. 12, no. 10, 2019, pp. 941–946. http://access.bl.uk/ark:/81055/vdc_100092812471.0x000007